Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nancy Yu
Affiliation
2Sunnybrook Research Institute
ORCID
Career Start Year
2000
Papers
18
H Index
11
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36657708
The c-Myc targeting hnRNPAB promotes lung adenocarcinoma cell proliferation via stabilization of CDK4 mRNA.
Int J Biochem Cell Biol
2023
35371611
Aging Impairs the Cellular Interplay between Myeloid Cells and Mesenchymal Cells during Skin Healing in Mice.
Aging Dis
2022
34185405
Serum amlyoid A: An inflammatory adipokine mediating postburn outcomes.
Clin Transl Med
2021
34470481
Development of a novel ELISA to detect total factor D in the presence of high levels of PEGylated anti-factor D Fab.
Bioanalysis
2021
32810382
Activation of ER stress signalling increases mortality after a major trauma.
J Cell Mol Med
2020
33179526
Development of an anti-drug antibody assay to detect anti-drug antibodies to protein and PEG in a PEGylated molecule.
Bioanalysis
2020
32735119
Immunoaffinity LC-MS/MS is more suitable than ELISA to quantify a PEGylated molecule in cynomolgus monkey serum.
Bioanalysis
2020
28067867
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Nat Commun
2017
25645927
HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin.
Mol Cell Biol
2015
26068950
miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).
Oncotarget
2015
24916506
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.
Blood
2014
23776679
miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.
PLoS One
2013
21411738
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
Sci Transl Med
2011
21868360
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
Sci Signal
2011
21673316
TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
Sci Signal
2011
19633198
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma.
Blood
2009
16369983
Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.
Cancer
2006
11114383
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
Immunity
2000
1 - 18 of 18
Column Actions
Search
Recommended Authors
Haolong Li
University of California san francisco
Career Start Year
2014
Number of shared co-authors
3
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year
2013
Number of shared co-authors
0
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year
2010
Number of shared co-authors
2
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
1
Sungyong You
Cedars-Sinai Medical Center
Career Start Year
2008
Number of shared co-authors
3
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year
2008
Number of shared co-authors
0
Ioannis Prassas
Mount Sinai Hospital
Career Start Year
2007
Number of shared co-authors
5
Jonathan Chou
University of California san francisco
Career Start Year
2005
Number of shared co-authors
3
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year
2000
Number of shared co-authors
0
Yan Liu
Chengdu Medical College
Career Start Year
1999
Number of shared co-authors
0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year
1998
Number of shared co-authors
0
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year
1998
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year
1997
Number of shared co-authors
2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Yunkai Yu
National Cancer Institute, National Institutes of Health
Career Start Year
1996
Number of shared co-authors
0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year
1996
Number of shared co-authors
0
Paul N Span
Radboud University Medical Center
Career Start Year
1993
Number of shared co-authors
1
Zhiqiang An
Zhengzhou University
Career Start Year
1992
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Ruo-Pan Huang
Raybiotech Co.
Career Start Year
1988
Number of shared co-authors
0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Ru-Fang Yeh
Genentech Inc.
Co-authored papers
3
Suchit Jhunjhunwala
Genentech Inc.
Co-authored papers
2
Paul C Boutros
University of California los angeles
Co-authored papers
2
Hyo Jin Kim
Department of Food Bioengineering, Jeju National University
Co-authored papers
2
Jill M Spoerke
Co-authored papers
2
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers
1
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers
1
Emmanouil Fokas
Universityhospital Frankfurt
Co-authored papers
1
Eric J Small
University of California san francisco
Co-authored papers
1
Alice Meng
Tufts University School of Medicine
Co-authored papers
1
Mark Frydenberg
Monash University
Co-authored papers
1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers
1
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers
1
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers
1
Robert G Bristow
University of Toronto
Co-authored papers
1
Damien Bolton
University of Melbourne
Co-authored papers
1
Winnie Lo
The Hospital for Sick Children
Co-authored papers
1
Sergey N Krylov
York University
Co-authored papers
1
Julia F Hopkins
Foundation Medicine Inc.
Co-authored papers
1
Sahar Jahangiri
Tehran University of Medical Sciences
Co-authored papers
1
Samira Taeb
Sunnybrook Research Institute
Co-authored papers
1
Elina Korpela
University of Toronto.
Co-authored papers
1
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers
1
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers
1
Pan Du
Co-authored papers
1
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers
1
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers
1
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
1
Julie Livingstone
University of California los angeles
Co-authored papers
1
1 - 30